Scholarlink

Background <p>Surgical resection, the primary treatment for locally recurrent rectal cancer (LRRC), is technically challenging. Transanal/transperineal minimally invasive surgery (Ta/Tp MIS) improves visualization and access through undisturbed planes. This study compared the short- and mid-term outcomes of Ta/Tp MIS with those of conventional non-Ta/Tp MIS for LRRC.</p> Methods <p>This retrospective observational study involved 98 patients who underwent curative-intent surgery for LRRC at a single tertiary cancer center between April 2008 and March 2022. Patients were classified into Ta/Tp MIS (<i>n</i> = 34) and non-Ta/Tp MIS (<i>n</i> = 64) groups. Perioperative and mid-term oncologic outcomes were compared, including operative time, blood loss, intraoperative transfusion, postoperative complications, pathological R0 resection, recurrence-free survival, local recurrence, and overall survival.</p> Results <p>Ta/Tp MIS was associated with reductions in resection time (median, 225 versus 252&#xa0;min; <i>p</i> = 0.0176), blood loss (median, 420.5 versus 1068&#xa0;mL; <i>p</i> &lt; 0.0001), and intraoperative transfusions (17.7% versus 48.4%, <i>p</i> = 0.0041), and tended toward a shorter operative time (median, 366.5 versus 418.5&#xa0;min; <i>p</i> = 0.1170). R0 resection (91.2% versus 89.1%), postoperative complications (overall Clavien–Dindo complication grade: 76.5% versus 75.0%, <i>p</i> = 1; grade ≥ 3: 41.2% versus 37.5%, <i>p</i> = 0.8282), 3-year recurrence-free survival (46.3% versus 44.2%, <i>p</i> = 0.9079), local recurrence (24.8% versus 37.7%, <i>p</i> = 0.3130), and 3-year overall survival (89.7% versus 77.7%, <i>p</i> = 0.2271) were comparable between groups.</p> Conclusions <p>Ta/Tp MIS appears to be a feasible surgical approach for selected patients with LRRC, and in this retrospective analysis, was associated with shorter resection time and reduced blood loss. No clear differences were observed in postoperative complications or short- to mid-term oncologic outcomes compared with conventional approaches.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Short- and mid-term outcomes of transanal/transperineal minimally invasive surgery for locally recurrent rectal cancer

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年5月1日

查看全文
  • Y. Tsukada,
  • S. Sasaki,
  • T. Mori,
  • M. Wakabayashi,
  • T. Ikeno,
  • K. Ikeda,
  • H. Hasegawa,
  • Y. Nishizawa,
  • M. Ito

摘要

Background

Surgical resection, the primary treatment for locally recurrent rectal cancer (LRRC), is technically challenging. Transanal/transperineal minimally invasive surgery (Ta/Tp MIS) improves visualization and access through undisturbed planes. This study compared the short- and mid-term outcomes of Ta/Tp MIS with those of conventional non-Ta/Tp MIS for LRRC.

Methods

This retrospective observational study involved 98 patients who underwent curative-intent surgery for LRRC at a single tertiary cancer center between April 2008 and March 2022. Patients were classified into Ta/Tp MIS (n = 34) and non-Ta/Tp MIS (n = 64) groups. Perioperative and mid-term oncologic outcomes were compared, including operative time, blood loss, intraoperative transfusion, postoperative complications, pathological R0 resection, recurrence-free survival, local recurrence, and overall survival.

Results

Ta/Tp MIS was associated with reductions in resection time (median, 225 versus 252 min; p = 0.0176), blood loss (median, 420.5 versus 1068 mL; p < 0.0001), and intraoperative transfusions (17.7% versus 48.4%, p = 0.0041), and tended toward a shorter operative time (median, 366.5 versus 418.5 min; p = 0.1170). R0 resection (91.2% versus 89.1%), postoperative complications (overall Clavien–Dindo complication grade: 76.5% versus 75.0%, p = 1; grade ≥ 3: 41.2% versus 37.5%, p = 0.8282), 3-year recurrence-free survival (46.3% versus 44.2%, p = 0.9079), local recurrence (24.8% versus 37.7%, p = 0.3130), and 3-year overall survival (89.7% versus 77.7%, p = 0.2271) were comparable between groups.

Conclusions

Ta/Tp MIS appears to be a feasible surgical approach for selected patients with LRRC, and in this retrospective analysis, was associated with shorter resection time and reduced blood loss. No clear differences were observed in postoperative complications or short- to mid-term oncologic outcomes compared with conventional approaches.